US FDA approves GSK's drug for liver disease related itching
Go back to US FDA approves GSK's drug for liver disease related itching| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 50.39 -0.43 (0.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.82 | 52 Week High | $45.58 | |||
| Open | $50.62 | 52 Week Low | $37.82 | |||
| Day High | $50.82 | P/E | N/A | |||
| Day Low | $50.31 | EPS | $0.00 | |||
| Volume | 998,626 | |||||
